Your browser doesn't support javascript.
loading
Cytokine-directed therapy with tocilizumab for immune checkpoint inhibitor-related hemophagocytic lymphohistiocytosis.
Özdemir, B C; Latifyan, S; Perreau, M; Fenwick, C; Alberio, L; Waeber, G; Spertini, F; de Leval, L; Michielin, O; Obeid, M.
Affiliation
  • Özdemir BC; Centre Hospitalier Universitaire Vaudois (CHUV), Service of Medical Oncology Department of Oncology, Lausanne, Switzerland; International Cancer Prevention Institute, Epalinges, Switzerland.
  • Latifyan S; Centre Hospitalier Universitaire Vaudois (CHUV), Service of Medical Oncology Department of Oncology, Lausanne, Switzerland.
  • Perreau M; Centre Hospitalier Universitaire Vaudois (CHUV), Service of Immunology and Allergy, Department of Medicine, Lausanne, Switzerland; University Hospital of Lausanne, Lausanne, Switzerland.
  • Fenwick C; Centre Hospitalier Universitaire Vaudois (CHUV), Service of Immunology and Allergy, Department of Medicine, Lausanne, Switzerland.
  • Alberio L; University Hospital of Lausanne, Lausanne, Switzerland; Centre Hospitalier Universitaire Vaudois (CHUV), Service of Hematology Division, Department of Oncology and Central Hematology Laboratory, Department of Laboratory Medicine and Pathology, Lausanne, Switzerland.
  • Waeber G; Centre Hospitalier Universitaire Vaudois (CHUV), Service of Immunology and Allergy, Department of Medicine, Lausanne, Switzerland; University Hospital of Lausanne, Lausanne, Switzerland.
  • Spertini F; Centre Hospitalier Universitaire Vaudois (CHUV), Service of Immunology and Allergy, Department of Medicine, Lausanne, Switzerland; University Hospital of Lausanne, Lausanne, Switzerland.
  • de Leval L; University Hospital of Lausanne, Lausanne, Switzerland; Centre Hospitalier Universitaire Vaudois (CHUV), Institute of Pathology, Department of Laboratory Medicine and Pathology, Lausanne, Switzerland.
  • Michielin O; Centre Hospitalier Universitaire Vaudois (CHUV), Service of Medical Oncology Department of Oncology, Lausanne, Switzerland; University Hospital of Lausanne, Lausanne, Switzerland.
  • Obeid M; Centre Hospitalier Universitaire Vaudois (CHUV), Service of Immunology and Allergy, Department of Medicine, Lausanne, Switzerland; University Hospital of Lausanne, Lausanne, Switzerland; Centre Hospitalier Universitaire Vaudois (CHUV), Vaccine and Immunotherapy Center, Lausanne, Switzerland. Electro
Ann Oncol ; 31(12): 1775-1778, 2020 12.
Article in En | MEDLINE | ID: mdl-32858151
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphohistiocytosis, Hemophagocytic / Immune Checkpoint Inhibitors Limits: Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2020 Document type: Article Affiliation country: Switzerland Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphohistiocytosis, Hemophagocytic / Immune Checkpoint Inhibitors Limits: Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2020 Document type: Article Affiliation country: Switzerland Country of publication: United kingdom